Clinical Characteristics and Outcome of Infective Endocarditis Involving Implantable Cardiac Devices

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorATHAN, Eugene
dc.contributor.authorCHU, Vivian H.
dc.contributor.authorTATTEVIN, Pierre
dc.contributor.authorSELTON-SUTY, Christine
dc.contributor.authorJONES, Phillip
dc.contributor.authorNABER, Christoph
dc.contributor.authorMIRO, Jose M.
dc.contributor.authorNINOT, Salvador
dc.contributor.authorFERNANDEZ-HIDALGO, Nuria
dc.contributor.authorDURANTE-MANGONI, Emanuele
dc.contributor.authorSPELMAN, Denis
dc.contributor.authorHOEN, Bruno
dc.contributor.authorLEJKO-ZUPANC, Tatjana
dc.contributor.authorCECCHI, Enrico
dc.contributor.authorTHUNY, Franck
dc.contributor.authorHANNAN, Margaret M.
dc.contributor.authorPAPPAS, Paul
dc.contributor.authorHENRY, Margaret
dc.contributor.authorFOWLER JR., Vance G.
dc.contributor.authorCROWLEY, Anna Lisa
dc.contributor.authorWANG, Andrew
dc.contributor.groupauthorICE-PCS Investigators
dc.contributor.groupauthorGRINBERG, Max
dc.contributor.groupauthorMANSUR, Alfredo José
dc.contributor.groupauthorSICILIANO, Rinaldo Focaccia
dc.contributor.groupauthorSTRABELLI, Tania Mara Varejao
dc.contributor.groupauthorVIEIRA, Marcelo Luiz Campos
dc.date.accessioned2019-08-20T14:53:52Z
dc.date.available2019-08-20T14:53:52Z
dc.date.issued2012
dc.description.abstractContext Infection of implantable cardiac devices is an emerging disease with significant morbidity, mortality, and health care costs. Objectives To describe the clinical characteristics and outcome of cardiac device infective endocarditis (CDIE) with attention to its health care association and to evaluate the association between device removal during index hospitalization and outcome. Design, Setting, and Patients Prospective cohort study using data from the International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS), conducted June 2000 through August 2006 in 61 centers in 28 countries. Patients were hospitalized adults with definite endocarditis as defined by modified Duke endocarditis criteria. Main Outcome Measures In-hospital and 1-year mortality. Results CDIE was diagnosed in 177 (6.4% [95% CI, 5.5%-7.4%]) of a total cohort of 2760 patients with definite infective endocarditis. The clinical profile of CDIE included advanced patient age (median, 71.2 years [interquartile range, 59.8-77.6]); causation by staphylococci (62 [35.0% {95% CI, 28.0%-42.5%}] Staphylococcus aureus and 56 [31.6% {95% CI, 24.9%-39.0%}] coagulase-negative staphylococci); and a high prevalence of health care-associated infection (81 [45.8% {95% CI, 38.3%-53.4%}]). There was coexisting valve involvement in 66 (37.3% [95% CI, 30.2%-44.9%]) patients, predominantly tricuspid valve infection (43/177 [24.3%]), with associated higher mortality. In-hospital and 1-year mortality rates were 14.7% (26/177 [95% CI, 9.8%-20.8%]) and 23.2% (41/177 [95% CI, 17.2%-30.1%]), respectively. Proportional hazards regression analysis showed a survival benefit at 1 year for device removal during the initial hospitalization (28/141 patients [19.9%] who underwent device removal during the index hospitalization had died at 1 year, vs 13/34 [38.2%] who did not undergo device removal; hazard ratio, 0.42 [95% CI, 0.22-0.82]). Conclusions Among patients with CDIE, the rate of concomitant valve infection is high, as is mortality, particularly if there is valve involvement. Early device removal is associated with improved survival at 1 year. JAMA. 2012;307(16):1727-1735eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipAmerican Heart Association
dc.description.sponsorshipCubist
dc.description.sponsorshipNovartis
dc.description.sponsorshipFondo de Investigaciones Sanitarias (FIS, Spanish Ministry of Health)
dc.description.sponsorshipNational Institutes of Health
dc.description.sponsorshipRIS-III (Spanish Network for AIDS Research)
dc.description.sponsorshipPfizer
dc.description.sponsorshipMSD
dc.description.sponsorshipAstellas
dc.description.sponsorshipMerck
dc.description.sponsorshipTheravance
dc.description.sponsorshipCerexa
dc.description.sponsorshipAdvanced Liquid Logic
dc.description.sponsorshipMedImmune
dc.description.sponsorshipGilead Sciences
dc.description.sponsorshipEdwards Lifesciences
dc.description.sponsorshipAbbott Vascular
dc.description.sponsorshipMinisterio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid, Spain
dc.description.sponsorshipSpanish Network for Research in Infectious Diseases [REIPI RD06/0008]
dc.description.sponsorshipInstituto de Salud Carlos III, Madrid, Spain [INT10/219]
dc.description.sponsorshipDepartament de Salut de la Generalitat de Catalunya, Barcelona, Spain
dc.identifier.citationJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, v.307, n.16, p.1727-1735, 2012
dc.identifier.doi10.1001/jama.2012.497
dc.identifier.eissn1538-3598
dc.identifier.issn0098-7484
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33302
dc.language.isoeng
dc.publisherAMER MEDICAL ASSOCeng
dc.relation.ispartofJama-Journal of the American Medical Association
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright AMER MEDICAL ASSOCeng
dc.subject.othercardioverter-defibrillator infectioneng
dc.subject.otherpermanent pacemakereng
dc.subject.othervalve endocarditiseng
dc.subject.otherrisk-factorseng
dc.subject.othermanagementeng
dc.subject.otherdiagnosiseng
dc.subject.othermortalityeng
dc.subject.otherprogresseng
dc.subject.wosMedicine, General & Internaleng
dc.titleClinical Characteristics and Outcome of Infective Endocarditis Involving Implantable Cardiac Deviceseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryAustrália
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryAlemanha
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countryIrlanda
hcfmusp.affiliation.countryEslovênia
hcfmusp.affiliation.countryisoie
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisoau
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisode
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisosi
hcfmusp.author.externalATHAN, Eugene:Barwon Hlth, Dept Infect Dis, Geelong, Vic, Australia
hcfmusp.author.externalCHU, Vivian H.:Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA
hcfmusp.author.externalTATTEVIN, Pierre:Pontchaillou Univ, ICU, Rennes, France
hcfmusp.author.externalSELTON-SUTY, Christine:CHU Nancy Brabois, Nancy, France
hcfmusp.author.externalJONES, Phillip:Univ New S Wales, Sydney, NSW, Australia
hcfmusp.author.externalNABER, Christoph:W German Heart Ctr, Dept Cardiol, Essen, Germany
hcfmusp.author.externalMIRO, Jose M.:Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain
hcfmusp.author.externalNINOT, Salvador:Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain
hcfmusp.author.externalFERNANDEZ-HIDALGO, Nuria:Hosp Univ Vall Hebron, Barcelona, Spain
hcfmusp.author.externalDURANTE-MANGONI, Emanuele:Univ Naples 2, Monaldi Hosp, Naples, Italy
hcfmusp.author.externalSPELMAN, Denis:Alfred Hosp, Melbourne, Vic, Australia
hcfmusp.author.externalHOEN, Bruno:Univ Med Ctr Besancon, Besancon, France
hcfmusp.author.externalLEJKO-ZUPANC, Tatjana:Med Ctr Ljubljana, Ljubljana, Slovenia
hcfmusp.author.externalCECCHI, Enrico:Maria Vittoria Hosp, Turin, Italy
hcfmusp.author.externalTHUNY, Franck:Fac Med Marseille, F-13385 Marseille, France
hcfmusp.author.externalHANNAN, Margaret M.:Mater Univ Hosp, Dept Microbiol, Dublin, Ireland
hcfmusp.author.externalPAPPAS, Paul:Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA
hcfmusp.author.externalHENRY, Margaret:Barwon Hlth, Dept Infect Dis, Geelong, Vic, Australia
hcfmusp.author.externalFOWLER JR., Vance G.:Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA
hcfmusp.author.externalCROWLEY, Anna Lisa:Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
hcfmusp.author.externalWANG, Andrew:Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
hcfmusp.citation.scopus238
hcfmusp.description.beginpage1727
hcfmusp.description.endpage1735
hcfmusp.description.issue16
hcfmusp.description.volume307
hcfmusp.origemWOS
hcfmusp.origem.pubmed22535857
hcfmusp.origem.scopus2-s2.0-84860212453
hcfmusp.origem.wosWOS:000303147500026
hcfmusp.publisher.cityCHICAGOeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceARBER N, 1994, MEDICINE, V73, P299, DOI 10.1097/00005792-199411000-00003eng
hcfmusp.relation.referenceBaddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665eng
hcfmusp.relation.referenceBaman TS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P129, DOI 10.1161/CIRCEP.108.816868eng
hcfmusp.relation.referenceBenito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004eng
hcfmusp.relation.referenceCabell CH, 2004, AM HEART J, V147, P582, DOI 10.1016/j.ahj.2003.06.005eng
hcfmusp.relation.referenceCabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90eng
hcfmusp.relation.referenceCabell CH, 2002, INFECT DIS CLIN N AM, V16, P255, DOI 10.1016/S0891-5520(01)00007-1eng
hcfmusp.relation.referenceCacoub P, 1998, AM J CARDIOL, V82, P480, DOI 10.1016/S0002-9149(98)00365-8eng
hcfmusp.relation.referenceChamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097eng
hcfmusp.relation.referenceChua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011eng
hcfmusp.relation.referenceDa Costa A, 1998, CIRCULATION, V97, P1791, DOI 10.1161/01.CIR.97.18.1791eng
hcfmusp.relation.referenceDa Costa A, 1998, CIRCULATION, V97, P1796, DOI 10.1161/01.CIR.97.18.1796eng
hcfmusp.relation.referenceDANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203eng
hcfmusp.relation.referenceDarouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415eng
hcfmusp.relation.referenceDuval X, 2004, CLIN INFECT DIS, V39, P68, DOI 10.1086/421493eng
hcfmusp.relation.referenceFerguson TB, 1996, J THORAC CARDIOV SUR, V111, P742, DOI 10.1016/S0022-5223(96)70334-3eng
hcfmusp.relation.referenceFowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012eng
hcfmusp.relation.referenceFriedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007eng
hcfmusp.relation.referenceGreenspon AJ, 2012, J AM COLL CARDIOL, V59, P681, DOI 10.1016/j.jacc.2011.11.011eng
hcfmusp.relation.referenceGreenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033eng
hcfmusp.relation.referenceJarcho JA, 2006, NEW ENGL J MED, V355, P288, DOI 10.1056/NEJMct055185eng
hcfmusp.relation.referenceKlug D, 1997, CIRCULATION, V95, P2098, DOI 10.1161/01.CIR.95.8.2098eng
hcfmusp.relation.referenceKlug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664eng
hcfmusp.relation.referenceLe KY, 2011, PACE, V34, P450, DOI 10.1111/j.1540-8159.2010.02991.xeng
hcfmusp.relation.referenceLi JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753eng
hcfmusp.relation.referenceMassoure PL, 2007, PACE, V30, P12eng
hcfmusp.relation.referenceMurdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603eng
hcfmusp.relation.referenceSohail MR, 2008, MAYO CLIN PROC, V83, P46, DOI 10.4065/83.1.46eng
hcfmusp.relation.referenceSohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072eng
hcfmusp.relation.referenceUslan DZ, 2007, ARCH INTERN MED, V167, P669, DOI 10.1001/archinte.167.7.669eng
hcfmusp.relation.referenceWang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354eng
hcfmusp.scopus.lastupdate2024-05-10
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_ATHAN_Clinical_Characteristics_and_Outcome_of_Infective_Endocarditis_Involving_2012.PDF
Tamanho:
240.99 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/47